Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K073006

    Validate with FDA (Live)

    Manufacturer
    Date Cleared
    2008-05-29

    (218 days)

    Product Code
    Regulation Number
    882.5320
    Age Range
    All
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticPediatricDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The OSTEOTRANS™-MX Bioabsorbable Bone Fixation System is intended for use in trauma and reconstructive procedures of the craniofacial skeleton, including fracture of the cranium, infant craniofacial surgery (i.e. craniosynostosis, congenital malformations), pediatric reconstructive procedures, reconstructive procedures of the cranium, craniotomy flap fixation.

    Device Description

    The OSTEOTRANS™-MX Bioabsorbable Bone Fixation System devices are the sterile, single-use bone plates, meshes and screws manufactured from composites of hydroxyapatite and poly-L-lactide (HA/PLLA). Plates, meshes and screws are provided with various shapes and sizes typical of other marketed fixation devices.

    Used properly, in the presence of adequate immobilization, the OSTEOTRANS" MX Bioabsorbable Bone Fixation System devices maintain accurate alignment of bone fractures and osteotomies.

    AI/ML Overview

    The provided text describes the OSTEOTRANS™-MX Bioabsorbable Bone Fixation System and its substantial equivalence to predicate devices, but it does not contain information about specific acceptance criteria or a study designed to prove the device meets such criteria.

    Instead, the document focuses on:

    • Intended Use Statement: Listing the anatomical regions and conditions for which the device is indicated.
    • Device Description: Explaining the materials (hydroxyapatite and poly-L-lactide HA/PLLA composites) and general form (plates, meshes, screws).
    • Summary of Technology: Stating that the device has the "same technological characteristics (i.e., design and material) when compared to the predicate devices" and that "Performance data demonstrate that the OSTEOTRANS™-MX Bioabsorbable Bone Fixation System has the requisite strength and favorable degradation profile to provide sufficient and sustained bone fixation for intended uses."

    The document relies heavily on demonstrating substantial equivalence to previously cleared predicate devices (K010352, K992355, K971870, K992905, K003549, K062819, K061881) rather than presenting new clinical study data with defined acceptance criteria. The statement about "Performance data" is generic and does not refer to a specific study detailed in this 510(k) summary.

    Therefore, I cannot populate the requested table or answer the questions regarding sample size, data provenance, experts, adjudication, MRMC studies, standalone performance, or ground truth establishment based on the provided text. The 510(k) process for this device appears to rely on demonstrating similarity to already approved devices.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1